Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Gilead Sciences, Inc.
Scientific Title
A Phase 3, Randomized, Open-Label Study Evaluating Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma